Bio-Rad Laboratories, Inc.
US ˙ NYSE ˙ US0905722072

SecurityBIO / Bio-Rad Laboratories, Inc.
InstitutionKBC Group NV
Latest Disclosed Ownership1,169 shares
Latest Disclosed Value $ 326
KBC Group NV ownership in BIO / Bio-Rad Laboratories, Inc.

On May 7, 2026 - KBC Group NV filed a 13F-HR form disclosing ownership of 1,169 shares of Bio-Rad Laboratories, Inc. (US:BIO) valued at $325,859 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 1,169 shares of Bio-Rad Laboratories, Inc.. The current value of the position is $356,346 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F BIO RAD LABS CL A 090572207 1,169 0 0.00 0 0.0004
2026-01-26 2025-12-31 13F BIO RAD LABS CL A 090572207 1,169 -293 -20.04 0 0.0008
2026-01-20 2025-09-30 13F BIO RAD LABS CL A 090572207 1,462 0 0.00 0 0.0010
2025-08-08 2025-06-30 13F BIO RAD LABS CL A 090572207 1,462 165 12.72 0 0.0010
2025-04-25 2025-03-31 13F BIO RAD LABS CL A 090572207 1,297 -984 -43.14 0 0.0010
2025-01-22 2024-12-31 13F BIO RAD LABS CL A 090572207 2,281 -814 -26.30 1 -100.00 0.0021
2024-11-06 2024-09-30 13F BIO RAD LABS CL A 090572207 3,095 1,400 82.60 1 0.0031
2024-07-17 2024-06-30 13F BIO RAD LABS CL A 090572207 1,695 -557 -24.73 0 0.0014
2024-05-08 2024-03-31 13F BIO RAD LABS CL A 090572207 2,252 -1,044 -31.67 1 -100.00 0.0025
2024-02-13 2023-12-31 13F BIO RAD LABS CL A 090572207 3,296 -1,534 -31.76 1 0.00 0.0038
2024-02-15 2023-09-30 13F/A-1 BIO RAD LABS CL A 090572207 4,830 -548 -10.19 2 -50.00 0.0071
2023-11-22 2023-09-30 13F BIO RAD LABS CL A 090572207 4,731 0 2 0.0075
2024-02-15 2023-06-30 13F/A-1 BIO RAD LABS CL A 090572207 5,378 1,781 49.51 2 100.00 0.0084
2023-07-28 2023-06-30 13F BIO RAD LABS CL A 090572207 4,731 1,896 2 0.0075
2024-02-14 2023-03-31 13F/A-1 BIO RAD LABS CL A 090572207 3,597 -284 -7.32 2 0.00 0.0073
2023-05-04 2023-03-31 13F BIO RAD LABS CL A 090572207 2,835 1,245 1 0.0064
2024-02-14 2022-12-31 13F/A-1 BIO RAD LABS CL A 090572207 3,881 2,263 139.86 2 0.0079
2023-02-13 2022-12-31 13F BIO RAD LABS CL A 090572207 1,590 -28 1 0.0000
2024-02-15 2022-09-30 13F/A-1 BIO RAD LABS CL A 090572207 1,618 28 1.76 1 0.0035
2022-11-08 2022-09-30 13F BIO RAD LABS CL A 090572207 1,590 0 663 0.0035
2024-02-14 2022-06-30 13F/A-1 BIO RAD LABS CL A 090572207 1,590 80 5.30 1 -100.00 0.0039
2022-07-26 2022-06-30 13F BIO RAD LABS CL A 090572207 1,590 80 787 0.0040
2024-02-14 2022-03-31 13F/A-1 BIO RAD LABS CL A 090572207 1,510 -29,581 -95.14 1 -100.00 0.0034
2022-05-06 2022-03-31 13F BIO RAD LABS CL A 090572207 1,510 -29,581 850 0.0031
2024-02-14 2021-12-31 13F/A-1 BIO RAD LABS CL A 090572207 31,091 -1,844 -5.60 23 -99.91 0.0775
2022-02-03 2021-12-31 13F BIO RAD LABS CL A 090572207 31,091 -1,844 23,491 0.0736
2021-11-10 2021-09-30 13F BIO RAD LABS CL A 090572207 32,935 29,143 768.54 24,568 905.65 0.0901
2022-02-15 2021-06-30 13F/A-1 BIO RAD LABS CL A 090572207 3,792 673 21.58 2,443 37.17 0.0088
2021-08-11 2021-06-30 13F BIO RAD LABS CL A 090572207 3,792 673 2,443 0.0088
2022-02-14 2021-03-31 13F/A-1 BIO RAD LABS CL A 090572207 3,119 779 33.29 1,781 -86.94 0.0072
2021-04-26 2021-03-31 13F BIO-RAD LABORATORIES-A CL A 090572207 3,119 779 1,781 0.0072
2022-02-14 2020-12-31 13F/A-1 BIO RAD LABS CL A 090572207 2,340 0 0.00 13,641 1,031.09 0.0064
2021-02-10 2020-12-31 13F BIO RAD LABS CL A 090572207 2,340 0 1,364 0.0063
2022-02-14 2020-09-30 13F/A-1 BIO RAD LABS CL A 090572207 2,340 -34,372 -93.63 1,206 -92.72 0.0071
2020-10-28 2020-09-30 13F BIO RAD LABS CL A 090572207 2,340 -34,372 1,206 0.0071
2022-02-14 2020-06-30 13F/A-1 BIO RAD LABS CL A 090572207 36,712 17,420 90.30 16,576 145.10 0.1095
2020-08-10 2020-06-30 13F BIO RAD LABS CL A 090572207 36,712 17,420 16,576 0.1109
2020-05-04 2020-03-31 13F BIO RAD LABS CL A 090572207 19,292 17,723 1,129.57 6,763 1,064.03 0.0566
2020-02-11 2019-12-31 13F BIO RAD LABS CL A 090572207 1,569 1,569 581 0.0037
2016-02-11 2015-12-31 13F BIO RAD LABS CL A 090572207 0 -2,232 -100.00 0 -100.00
2015-11-12 2015-09-30 13F BIO RAD LABS CL A 090572207 2,232 2,232 300 0.0060
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.